Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G L Clayman

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
The Journal of Investigative Dermatology|April 1, 1994
Keratinocyte transglutaminase expression varies in squamous cell carcinomasM Duvic, D C Nelson, M Annarella, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 29, 2000
Expression of protein mediators of type I interferon signaling in human squamous cell carcinoma of the skinJ L Clifford, D G Menter, X Yang, et al.
Archives of Otolaryngology--Head & Neck Surgery|January 1, 1992
Acute-phase proteins in patients with head and neck cancer treated with interleukin 2/interferon alfaG L Clayman, F J Liu, H E Savage, et al.
Archives of Otolaryngology--Head & Neck Surgery|February 1, 1995
Laryngeal preservation for advanced laryngeal and hypopharyngeal cancersG L Clayman, R S Weber, O Guillamondegui, et al.
Cancer|June 4, 1998
The prognostic significance of the biomarkers p21WAF1/CIP1, p53, and bcl-2 in laryngeal squamous cell carcinomaY T Jin, S Kayser, B L Kemp, et al.
Cancer Research|August 15, 1995
p53 mutations in nonmelanoma skin cancer of the head and neck: molecular evidence for field cancerizationS Kanjilal, S S Strom, G L Clayman, et al.
Archives of Otolaryngology--Head & Neck Surgery|October 16, 1999
Biochemoprevention for dysplastic lesions of the upper aerodigestive tractV A Papadimitrakopoulou, G L Clayman, D M Shin, et al.
Cancer|April 1, 1997
Induction chemotherapy followed by radiotherapy versus radiotherapy alone in patients with advanced nasopharyngeal carcinoma: results of a matched cohort studyF B Geara, B S Glisson, G Sanguineti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1997
Head and neck squamous cell growth suppression using adenovirus-p53-FLAG: a potential marker for gene therapy trialsS M Overholt, T J Liu, D L Taylor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinomaD M Shin, B S Glisson, F R Khuri, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
The Journal of Investigative Dermatology|April 1, 1994
Keratinocyte transglutaminase expression varies in squamous cell carcinomasM Duvic, D C Nelson, M Annarella, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 29, 2000
Expression of protein mediators of type I interferon signaling in human squamous cell carcinoma of the skinJ L Clifford, D G Menter, X Yang, et al.
Archives of Otolaryngology--Head & Neck Surgery|January 1, 1992
Acute-phase proteins in patients with head and neck cancer treated with interleukin 2/interferon alfaG L Clayman, F J Liu, H E Savage, et al.
Archives of Otolaryngology--Head & Neck Surgery|February 1, 1995
Laryngeal preservation for advanced laryngeal and hypopharyngeal cancersG L Clayman, R S Weber, O Guillamondegui, et al.
Cancer|June 4, 1998
The prognostic significance of the biomarkers p21WAF1/CIP1, p53, and bcl-2 in laryngeal squamous cell carcinomaY T Jin, S Kayser, B L Kemp, et al.
Cancer Research|August 15, 1995
p53 mutations in nonmelanoma skin cancer of the head and neck: molecular evidence for field cancerizationS Kanjilal, S S Strom, G L Clayman, et al.
Archives of Otolaryngology--Head & Neck Surgery|October 16, 1999
Biochemoprevention for dysplastic lesions of the upper aerodigestive tractV A Papadimitrakopoulou, G L Clayman, D M Shin, et al.
Cancer|April 1, 1997
Induction chemotherapy followed by radiotherapy versus radiotherapy alone in patients with advanced nasopharyngeal carcinoma: results of a matched cohort studyF B Geara, B S Glisson, G Sanguineti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 1, 1997
Head and neck squamous cell growth suppression using adenovirus-p53-FLAG: a potential marker for gene therapy trialsS M Overholt, T J Liu, D L Taylor, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinomaD M Shin, B S Glisson, F R Khuri, et al.
Pageof 10